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Abstract Large, unexplained, but possibly related dispar-
ities exist between heart disease risks observed in differing
genders, educational levels, times, and studies. Such heart
disease disparities might be related to cumulative tobacco
smoke damage (smoke load) disparities that are overlooked
in standard assessments of point smoking status. So, I
reviewed possible relationships between smoke load and
heart disease levels across genders, educational strata,
years, and leading studies. Smoker heart disease risk
assessments in the Nurses Health Study (Nurses), Cancer
Prevention Study-II (CPS-II), and British Doctors studies
were compared and related to their likely selection and
misclassification biases. Relationships between smoke
loads and United States (US) education- and gender-
related heart disease mortality disparities were qualitatively
assessed using lung cancer rates as a smoke load proxy. The
high heart disease mortality risks observed in smoking
Nurses in 1980–2004 and in less educated US women in
2001 were qualitatively associated with their higher smoke
loads and lower selection and exposure misclassification
biases than in the CPS-II and Doctors studies. Smoking-
attributable heart disease death tolls and disparities extrap-
olated from mortality ratios from the CPS-II and Doctors
studies may be substantial underestimates. Such studies
appear to have compared convenience samples of light
smokers to lighter smokers instead of comparing represen-
tative smokers to the unexposed. Further efforts to
minimize smoke exposures and better quantify cumulative
smoking-attributable burdens are needed.
Keywords Smoking.IschemicHeartDisease.Mortality.
SocioeconomicStatus.Gender.Disparities
Introduction
Large, deadly, unexplained, but possibly related disparities
exist between heart disease risks observed in less versus
more educated groups, 1993 versus 2001, women versus
men [14], and different studies and definitions of “smok-
ing” [18, 33]. Thus, while at age 25–64 years, female heart
disease age-standardized mortality rates per 100,000 (rates)
fell in most groups, they inexplicably rose in the lowest
education (<12 years) US White women from 84 in 1993 to
98 per 100,000 in 2001 [14]. That 2001 rate was twice the
United States (US) male and six times the White female
heart disease mortality rates seen in the most educated (16+
years of education) in 2001 [14]. Also, unexplained are
disparities between the female smoker age-adjusted ische-
mic heart disease (IHD) mortality ratios of 3.3 (95%
confidence interval (CI) 2.9–3.8) in Nurses Health Study
(Nurse) smokers versus 1.6 (CI 1.4–1.7) in the Cancer
Prevention Study-II (CPS-II) from which official US and
global smoking-attributable heart disease mortality esti-
mates are extrapolated [18, 33]. Lastly, relationships
between smoking and US male/female mortality rate
disparities in 2001 that were reversed for lung cancer and
trending toward reversal for heart disease in the highly
educated are unexplained [14].
Given the large unexplained decreases in gender-
related and increases in education or smoking-related
heart disease mortality disparities noted above, a closer
review of the possible sources of such disparities seems
merited. So, I overviewed possible oversights in past
assessments of relationships of smoking to heart disease
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Methods
I contrasted methods and their relationships to IHD
mortality ratios in four leading cohort studies. The studies
selected were: (1) the Nurses Health Study (NHS) 1980–
2004 follow-up due to its recency, methodologic strengths,
and high mortality ratios in smokers; (2) CPS-II [33] since
it has been extrapolated into recent estimates of 443,000
annual US [1] and up to one billion global twenty-first
century smoking-attributable deaths [37]; and the British
(3) male and (4) female Doctors Studies, since they seem to
be earlier, smaller, British versions of the methods in CPS-
II [9–11, 33].
The NHS began with about 122,000 healthy, married US
female nurses ages 30 to 55 years from 11 states in 1976
[18], though only the 1980–2004 data were used in the
recent analyses I discuss (Tables 1 and 2). The NHS is
relatively unique among large cohort studies in recency, use
of biennial exposure reassessment, juried cause of death
assignment, and fixing of smoking status for analysis
purposes at the biennial assessment prior to the diagnosis
of vascular, neoplastic, or respiratory disease. Those
methods help to minimize exposure and outcome (detec-
tion) misclassification biases and confounding by nonfatal
diseases, respectively [18].
The CPS-II is the very large US cohort on which most
US and global smoking-attributable mortality estimates
are based. It began in 1982 with about 480,000 women
ages 45+years in cancer society member acquaintance
households [33]. The CPS-II cohort both used a definition
of “never smoker” that misclassifies smokers as “never
smokers”[7] and has subsequently been shown to have
disproportionately high education, life expectancy, and
probable smoking cessation rates and thus probably low
smoke exposures relative to the US population [31, 32].
The British male and female Doctors Studies are the
longest (1951–2001 and 1951–1972, respectively) early
large cohort studies of smoking effects. Since true “non-
smokers” were thought to be nonexistent at the time, less
regular smokers (those denying smoking at least one
cigarette daily for 365 days consecutively) were termed
never smokers at least near the initiation of the study in
1951 [7, 8].
Possible selection and misclassification biases in the
CPS-II, NHS, and Doctors studies were evaluated by
reviewing their methods including timing, enrollment
criteria, exclusions, smoking prevalence, age, “never” and
“current” smoker definitions, and means of cause of death
Table 1 Background information on the Nurses, CPS-II, and British Doctors studies
Study
Nurses Health [18] Cancer Prevention Study-II
(CPS-II) [33]
British Doctors Males [10] British Doctors Females
[9]
Analytic cohort
nos.
About 100,000 711,000, about 2/3 women 34,440, about 2/3 of
eligible male doctors
6,194
Enrollment 1976, but Kenfield excluded
1976–1980 data
Fall, 1982 1951 1951
End of follow-
up
2004 for Kenfield hazard
ratios [18]; 2002/2003 for
mortality rates [28]
12/31/1988 2001 1972
Enrollment
criteria
Initially healthy, female
married registered nurses
from 11 states
Friends, neighbors, and
acquaintances of American
Cancer Society volunteers
British male physicians British female
physicians
Exclusions 1976–1980 data and the
unmarried, or diseased [18]
Pipe, cigar, or unclassifiable
smokers
Users of any tobacco
except cigarettes
Users of any tobacco
except cigarettes
Initial current/
ever smoking
prevalence
28%/54.3% Age adjusted in White women,
20%/42%
∼80%/83% –/50%
Exposure
reassessment
Biennial until disease
diagnosed [18]
None in the 6 years analyzed Every 6–13 years Every 6–9 years
Outcome
assessment
Juried by experts with terminal
care records for 94% of deaths
Death certificate Death certificate unless
lung cancer
Death certificate unless
lung cancer
Ages analyzed 34–84 years 35+years ∼20+years ∼20+years
URL/link http://jama.ama-assn.org/cgi/
content/short/299/17/2037
http://cancercontrol.cancer.gov/
TCRB/monographs/8/index.
html
http://www.bmj.com/cgi/
content/abstract/
bmj.38142.554479.AEv1
http://www.ncbi.nlm.nih.
gov/pubmed/7417764?
dopt=Citation
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J. of Cardiovasc. Trans. Res. (2009) 2:267–273 269assignment (Table 1) and biases and/or mortality rate ratios
versus the general population (Table 2). Table 2 helps to
quantify selection bias possibly due to the disproportionate
selection of light “smokers” by comparing lung cancer or
all cause mortality rates in the cohort or similar groups to
the general population. One would expect representative
smokers to have far higher mortality rates than average
Americans, about ¾ of whom deny current smoking.
Table 2 helps to overview exposure misclassification bias
by comparing definitions of “smoking” in the cohort to the
types of smoke exposure overlooked by each definition of
“smoker.” Given the selection and exposure misclassifica-
tion biases in those studies (Tables 1 and 2), other more
representative exposure/outcome associations seem to be
needed. So, I qualitatively contrasted 1993 and 2001 US
female heart disease and lung cancer mortality rates and
smoking prevalence across educational strata [2, 14] since
such mortality rates were more current and widely used
than other (income, class, deprivation, …) socioeconomic
stratifications in the USA, lung cancer rates are a good
proxy for cumulative tobacco smoke damage (smoke load)
[19–22, 26], and US data had been used in the Nurses and
CPS-II analyses [18, 33].
Results
The studies reviewed addressed distinct populations,
times, and other background differences (Table 1);
definitions of “never” and “current” smoking with atten-
dant differences in exposure misclassification (Table 2);
and smoker IHD mortality ratios (Table 2). Still, each
study exhibited selection bias with narrow, skewed
eligibility criteria (Table 1), low participant fractions
(<3%), and/or low mortality rates, compared to the general
population (Table 2). Selection bias was substantial in
Nurses. Nurse “smokers” had little (1.19-fold at ages 70–
74) to no (0.87-fold at ages 50–54) more premature
mortality than nationally representative women yet thrice
the all-cause mortality rate of Nurse never smokers
(Table 2)[ 18, 28]. Selection bias was even clearer and
stronger in CPS-II women age 35+years, where “never”
and “current” smokers had lung cancer death rates 87%
and −49%, respectively, and all-cause death rates 65% and
39%, respectively, below all US female averages for the
1983–1988 period [29, 33]. Prominent epidemiologists
Peto, Thun, and Lopez wrote this about CPS-II: “…death
rates among the nonsmokers and the smokers in the CPS-
II study cannot be generalised even to the US, let alone to
other populations. For example, the probability that a 35-
year-old man will die before 70 is 34% at US 1985 death
rates, but only 13% and 32% at the non-smoker and
smoker death rates in years 3–6o fC P S - I I . ” [25].
Heartdiseaseand lungcancer mortality rates byeducation
stratum and year in White US women at working ages are
shown in Fig. 1. The data are for decedents from 43 states
who were age 25–64 years with recorded years of education
[14]. Smoke load (lung cancer rate in red and graphed on
the y-1 axis) and heart disease rate levels (graphed on the
right (y-2) axis) generally were closely proportional to each
other across education and time strata and both rose
proportionately in the least educated, were stable in high
school graduates, and fell in the most educated (Fig. 1).
Figure 2 contrasts male and female smoke loads, as
reflected in lung cancer rates, by the same year–education
strata as in Fig. 1. Smoke load changes from 1993 to 2001
ranged from a 22% increase in the least educated women to
1%, 17%, and 34% decreases in the least educated men and
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Fig. 1 United States White
female lung cancer and heart
disease mortality rates by year
and years of education, ages
25–64 years
270 J. of Cardiovasc. Trans. Res. (2009) 2:267–273the most educated women and men, respectively. By 2001,
the male/female lung cancer mortality rate ratios were 1.18
and 0.98 in those with 16+ versus 17+years of education,
respectively, and the heart disease rate ratio with 16+years
of education was 3, down from 4 in 1993 as their male
heart disease mortality rate fell 21 deaths/100,000, seven
times their female rate decline (Fig. 3).
Discussion
This study found large heart disease mortality disparities,
large smoke load disparities, and suggestive qualitative
relationships between higher smoke loads and higher heart
disease mortality levels across education levels, times,
genders, and studies. Thus, the highest female heart disease
and lung cancer rates and rate increases from 1993 to 2001
all occurred in the least educated females (Fig. 1), a group
underrepresented in CPS-II [33], while the greatest drops
all occurred in the most educated men (Figs. 2 and 3), a
group overrepresented in CPS-II [33]. As expected, reduced
selection and misclassification biases in Nurses appear to
have resulted in greater disparities between Nurse than
CPS-II female “current” versus “never” smoker exposures
and death rates. That is suggested by Nurse “smoker”
mortality ratios that are higher than in CPS-II women for
lung cancer or all-causes versus national averages (Table 2)
or for all-causes versus “never” smokers (age-adjusted all-
cause mortality ratios of 2.77 (CI 2.65–2.90) in Nurses
versus 1.9 (CI 1.9–2.0) in CPS-II women). In other words,
the improved definitions of “smoker” and more represen-
tative “smokers” in Nurses are associated with about 4-fold
higher “smoker” IHD mortality excesses (2.3 (age adjusted)
to 2.9 (multiply adjusted) in Nurses versus 0.6 to 0.8 in
CPS-II women where excess risk equals IHD mortality
ratios from Table 2, minus 1, the risk in the unexposed).
This study has several strengths. First, suggestions of
higher smoking-related heart disease mortality burdens with
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J. of Cardiovasc. Trans. Res. (2009) 2:267–273 271the higher quality cohort study methods in Nurses [18]
corroborate the seemingly strong relationship between
female smoke load and heart disease mortality rates across
educational disparities (Fig. 1). Second, the general popula-
tion lung cancer/heart disease rate associations (Fig. 1)
qualitatively support suggestions that improved measurement
of smoking will help account for more mortality disparities.
Lung cancer rates are preferred as smoke load measures
since they integrate several important aspects of exposure
existence, duration, and level that are overlooked by self-
reported point smoking status. For example, mortality is
strongly related to forgotten [35], secondhand, insensible [3],
and durational [27] aspects of exposure that are ignored in
assessments of self-reported current active smoking. Second,
the 1980–2004 Nurse [18] and 2001 national information
studied is far more recent and less prone to selection,
misclassification, and detection biases than are the 1982–
1988 CPS-II and 1951–1972 female doctors data [35].
This review has weaknesses. Only three of the most
prominent studies were discussed in depth, and all of them
had some selection bias (Table 2). Despite their reduced
misclassification bias compared to CPS-II, Nurses still had
probably significant misclassification biases from secondhand
and insensible smoking [3] and possibly from forgetfulness
[35], never “regularly” smoking, or cessation periods between
biennial reports of active smoking. Besides smoke load, other
exposures could have differed between the studies. However,
adjustment for numerous self-reported IHD risk factors raised
the Nurse “smoker” IHD mortality hazard ratio from 3.34 to
3.91, widening the disparity between Nurse versus female
CPS-II or Doctor mortality ratios [18]. The qualitative lung
cancer/IHD mortality rate association across education levels
(Fig. 1) exclude about seven states, are ecologic, and are based
on proxy-reported decedent education levels and intercensal
persons-at-risk estimates [14]. Lastly, little mention was made
of the importance of smoking-related female lung cancer and
other non-heart disease deaths. Yet, lung cancer alone killed
nearly twice as many US women as breast cancer in 2005
[29], was increasingly disparate across education strata
(Fig. 2), and appears to be persisting more in educated
w o m e nt h a nm e n( F i g .2). Also, the Kenfield reanalysis of
Nurses data linked smoking to both considerably greater
mortality ratios and ranges of diseases than are included in
official smoking-attributable mortality estimates [18].
Both this and several prior studies imply that heart
disease mortality rate disparities might be largely linked to
smoke load disparities and official estimates of death tolls
from smoking may deserve to be raised substantially. A
similar prior review of differing lung cancer risks found the
differences to be largely due to differing smoke exposures
[35]. Previous underestimation of strong relationships
between smoking and heart disease mortality disparities
are suggested by (1) the heightened IHD risk estimates in
Nurses when exposure misclassification and selection biases
were reduced (Table 2), (2) persistent selection and misclas-
sification biases in the Nurses study albeit smaller biases
than in CPS-II, (3) close proportionality between the female
smoke load and heart disease mortality levels over time and
education in Fig. 1, and (4) prior papers. Jousilahti noted
both that nonparticipants in a high (84%) participation rate
survey had twice the tobacco-related disease mortality rate of
participants [17] and that smoker mortality relative risks fell
considerably with even two added years of cessation-related
misclassification of “current” smoking [16]. Taylor and Thun
showed substantial effects of possible CPS-II misclassifica-
tion of ex-smoking years as “smoking” years [32].
Wacholder et al. [36] Boffetta et al. [4] and Marshall et al.
[23, 24] each have noted that study risk estimates are very
sensitive to misclassification of exposure as occurred even in
Nurses (Table 2)[ 3]. Recent papers by Jha et al. [15]a n d
Gruer et al. [12] have suggested apparent dominant roles of
smoking in socioeconomic mortality disparities.
This study has several implications. First, reducing active,
secondhand, and insensible [3] smoking in all and especially
the less educated (Fig. 2) and reducing bias in studies
assessing or adjusting for smoking effects seem merited [23,
24, 36]. Second, as others have noted, development and use
of better smoke load biochemical markers or sentinel health
event smoke load bio-indices like lung cancer rates with
juried cause of death assessments may be useful [13]. Third,
increasing the numbers of studies which publish the absolute
smoke loads and heart disease mortality rates in their
exposed and control populations might allow both construc-
tion of smoke load/heart disease mortality rate dose–response
curves across studies and assessment of which parts of that
curve were best represented in individual cohorts.
Further research is needed to help better quantify and
communicate smoke load risks to women and men. Commu-
nicating with women may be especially pressing since
smoking prevalence, smoke loads, and/or heart disease
mortality rates were falling faster in men of working age,
thus rapidly trending toward female lung cancer and heart
disease death rates exceeding men in the most educated, some
northern states [6] and some northern European nations [37].
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